Arrowstreet Capital Limited Partnership Cuts Stock Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Arrowstreet Capital Limited Partnership lowered its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 39.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 731,662 shares of the medical instruments supplier's stock after selling 479,659 shares during the period. Arrowstreet Capital Limited Partnership owned about 0.37% of DENTSPLY SIRONA worth $13,887,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Vanguard Group Inc. boosted its stake in shares of DENTSPLY SIRONA by 0.3% during the 4th quarter. Vanguard Group Inc. now owns 20,183,260 shares of the medical instruments supplier's stock worth $383,078,000 after acquiring an additional 65,478 shares in the last quarter. First Eagle Investment Management LLC boosted its position in DENTSPLY SIRONA by 2.5% during the fourth quarter. First Eagle Investment Management LLC now owns 14,500,409 shares of the medical instruments supplier's stock worth $275,218,000 after purchasing an additional 348,532 shares in the last quarter. Nuance Investments LLC grew its holdings in DENTSPLY SIRONA by 25.0% in the fourth quarter. Nuance Investments LLC now owns 13,545,981 shares of the medical instruments supplier's stock valued at $257,103,000 after purchasing an additional 2,708,097 shares during the last quarter. Cooke & Bieler LP increased its position in shares of DENTSPLY SIRONA by 24.3% in the fourth quarter. Cooke & Bieler LP now owns 9,172,876 shares of the medical instruments supplier's stock valued at $174,101,000 after buying an additional 1,794,391 shares in the last quarter. Finally, Pacer Advisors Inc. raised its stake in shares of DENTSPLY SIRONA by 15,105.1% during the 4th quarter. Pacer Advisors Inc. now owns 4,503,591 shares of the medical instruments supplier's stock worth $85,478,000 after buying an additional 4,473,972 shares during the last quarter. 95.70% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Insider Buying and Selling

In related news, Director Gregory T. Lucier acquired 15,142 shares of the stock in a transaction dated Monday, March 3rd. The stock was bought at an average cost of $16.51 per share, with a total value of $249,994.42. Following the purchase, the director now directly owns 81,971 shares of the company's stock, valued at approximately $1,353,341.21. This represents a 22.66 % increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 0.52% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

A number of equities research analysts recently commented on XRAY shares. Barrington Research lowered their price objective on shares of DENTSPLY SIRONA from $24.00 to $20.00 and set an "outperform" rating on the stock in a research note on Friday, February 28th. Wells Fargo & Company lowered their price target on shares of DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating on the stock in a research report on Friday, February 28th. Mizuho cut their price objective on DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating for the company in a research report on Thursday, March 13th. Evercore ISI reaffirmed an "in-line" rating and issued a $20.00 target price on shares of DENTSPLY SIRONA in a research note on Tuesday, January 7th. Finally, Morgan Stanley dropped their price target on DENTSPLY SIRONA from $30.00 to $23.00 and set an "overweight" rating for the company in a research report on Tuesday, December 17th. Twelve analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to MarketBeat.com, the company has an average rating of "Hold" and an average price target of $23.33.

DENTSPLY SIRONA Trading Up 7.9 %

NASDAQ:XRAY traded up $1.00 during mid-day trading on Wednesday, reaching $13.66. The company's stock had a trading volume of 5,491,747 shares, compared to its average volume of 2,937,193. DENTSPLY SIRONA Inc. has a twelve month low of $12.18 and a twelve month high of $32.83. The company's fifty day simple moving average is $16.47 and its two-hundred day simple moving average is $19.34. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. The stock has a market cap of $2.72 billion, a P/E ratio of -6.60, a P/E/G ratio of 1.80 and a beta of 0.92.

DENTSPLY SIRONA Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, April 11th. Investors of record on Friday, March 28th will be issued a $0.16 dividend. The ex-dividend date of this dividend is Friday, March 28th. This represents a $0.64 dividend on an annualized basis and a yield of 4.69%. DENTSPLY SIRONA's payout ratio is -14.07%.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.